TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ANGO

AngioDynamics Inc

Healthcare · Medical Instruments & Supplies

15.50$ -1.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

AngioDynamics Inc (ANGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 267 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANGO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
727 712 704 708 700 698 698 705 694 784 778 836 690 725 732 596 584 589 582 561 556 554 543 553 558 558 543 533 494 500 325 318 294 292 285 280 266 270 261 267
152 148 145 154 151 152 157 168 121 143 143 315 166 132 129 153 142 150 146 141 131 132 128 143 151 159 153 164 175 185 197 193 173 175 172 168 157 161 156 163
37 36 36 48 48 50 52 74 25 43 42 228 84 41 27 54 48 58 54 48 35 34 24 29 25 30 30 45 58 61 78 76 55 54 45 56 39 42 38 54
39 37 37 49 49 51 54 75 26 44 42 228 84 41 27 54 48 58 54 48 35 34 24 29 25 30 30 45 58 61 78 76 55 54 45 56 39 42 38 54
50 50 46 46 41 42 42 39 40 43 44 44 33 34 36 34 34 34 33 35 35 38 42 56 54 53 51 53 50 52 49 50 40 43 49 43 43 44 46 48
58 57 58 55 55 54 57 39 50 51 52 40 45 50 55 60 53 50 49 49 49 48 48 51 58 63 64 55 60 64 58 61 65 66 63 62 62 66 59 52
47 47 46 45 44 44 43 42 42 42 41 24 25 28 28 28 29 30 40 37 50 43 44 45 46 46 46 44 48 – – – – – – – – – – –
361 361 361 361 361 361 361 361 383 427 424 348 348 360 359 202 201 201 201 201 201 202 201 201 201 201 200 159 159 159 0.0 0.0 – – – – – – – –
162 154 150 146 142 137 135 130 144 169 167 145 142 196 202 197 194 191 186 169 169 165 159 152 148 142 134 111 107 104 82 77 76 73 71 69 68 67 65 67
214 189 173 191 182 177 160 163 149 234 224 222 76 111 121 140 129 134 127 122 120 122 113 128 144 150 145 154 66 98 106 112 97 105 100 97 87 93 87 96
65 51 51 70 64 60 54 57 46 50 53 73 47 57 49 52 40 46 50 58 52 54 49 74 66 74 70 84 57 78 86 91 77 89 78 76 68 72 66 75
31 14 15 15 15 7.1 7.1 7.1 9.0 9.0 13 12 0.9 0.9 0.9 0.8 – – 30 2.4 2.4 2.5 2.5 8.8 2.6 2.5 9.9 15 4.7 1.7 1.6 4.7 4.8 5.0 5.0 2.2 2.2 1.7 1.7 –
16 15 15 18 17 22 16 16 17 19 18 23 17 18 18 19 14 16 17 20 23 24 22 28 29 35 36 40 25 38 35 38 31 35 30 33 32 35 29 32
101 110 93 91 90 89 88 87 85 139 127 124 – – 14 40 40 40 30 20 25 25 25 25 50 50 50 50 – – – – – – – – – – – –
513 523 532 517 518 521 538 543 545 550 554 615 614 614 610 456 455 454 455 439 436 432 430 424 414 408 398 378 428 401 219 206 197 187 186 183 179 176 173 171
-15 -1.0 1.9 -11 -11 -11 3.0 5.1 4.7 6.8 7.6 66 65 62 57 -100 -105 -109 -112 -132 -139 -147 -152 -158 -171 -180 -189 -211 -165 -194 -382 -395 -408 -419 -423 -429 -440 -446 -455 -466
37 37 37 37 37 37 37 38 37 38 38 38 38 38 38 38 38 38 38 39 39 39 39 39 39 39 40 40 40 40 40 40 41 41 41 41 41 41 42 42

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?